Skip to main content

Table 1 Patient demographics and characteristics

From: Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies

  

T2DM

  

T1DM

Parameter

Diet

OHA

OHA + Insulin

Insulin

Insulin

(n = 120)

(n = 513)

(n = 439)

(n = 442)

(n = 48)

Age [years]

64.9 ± 8.2

65.7 ± 8.5

65.1 ± 8.1

68.1 ± 9.2

52.9 ± 10.4

Gender [f/m]

33 / 87

174 / 339

136 / 303

135 / 307

21 / 27

DM duration [years]

3 (2–6)

6 (3–11)

12 (8–17)

16 (9–23)

31 (21–36)

BMI [kg/m2]

29.3 ± 4.1

30.5 ± 5.2

32.6 ± 5.5

30.7 ± 5.2

26.0 ± 3.8

HbA1c [%]

6.3 ± 0.7

6.8 ± 0.8

7.2 ± 1.0

7.1 ± 1.0

7.6 ± 1.0

  1. Data represent the mean ± SD or median (interquartile range) for each category.
  2. OHA, oral hypoglycaemic agent; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.